Experts present concept for zero peri-implantitis at EAO

EAO Monaco: Experts present concept for zero peri-implantitis

Prof. Anton Sculean (left) and Dr Roland Glauser at a recent symposium on zero peri-implantitis, held in May at EuroPerio11 in Austria. Prof. Sculean emphasised that prevention of peri-implantitis should take priority over treatment, while Dr Glauser highlighted the novel soft-tissue bond around Patent implants as a potential key to disease prevention. (Image: Dental JOURNAL)

Patent

Thu. 18. September 2025

save

MONACO: The zero peri-implantitis concept of the Patent Dental Implant System, designed to prevent disease onset and maintain long-term soft-tissue health, is in focus at the EAO–SFPIO joint meeting, which currently takes place in Monaco. The company has announced that leading researchers are available on-site to present current findings and exchange knowledge with congress participants.

Dr Roland Glauser, a practising implantologist and researcher specialising in comprehensive implantology from Switzerland, Prof. Anton Sculean, a leading periodontal researcher at the University of Bern in Switzerland, and Dr Pascal Karsenti, a French expert in implantology and periodontology and experienced user of Patent implants, are meeting delegates throughout the congress at the Patent Dental Implant System booth. They are discussing the scientific background of the concept, sharing clinical experience and answering questions from participants interested in the practical application of Patent implants.

Research highlights soft-tissue bond to prevent peri-implantitis

At the core of the concept is the world’s first demonstrated bond between peri-implant soft tissue and a transmucosal implant surface—a type of cell bond observed only around Patent implants.

This finding comes from a histological study conducted by Dr Glauser, Prof. Sculean, and Drs Peter Schüpbach and Dieter Bosshardt, which has not yet been published. The study suggests that the soft-tissue bond may act as a dynamic defence barrier, protecting peri-implant tissue from bacterial invasion, inflammation and disease progression. Complementary long-term clinical evidence supporting this mechanism has been reported by Brunello et al. in Germany and Karapataki et al. in Austria.^1,2

Delegates can visit Booth F02 to learn more about this novel cell bond and how Patent implants are helping to advance peri-implant tissue health.

More information can be found at www.mypatent.com.

Editorial note:

References

Brunello G, Rauch N, Becker K, Hakimi AR, Schwarz F, Becker J. Two-piece zirconia implants in the posterior mandible and maxilla: a cohort study with a follow-up period of 9 years. Clin Oral Implants Res. 2022 Dec;33(12):1233–44. doi: 10.1111/clr.14005.
Karapataki S, Vegh D, Payer M, Fahrenholz H, Antonoglou GN. Clinical performance of two-piece zirconia dental implants after 5 and up to 12 years. Int J Oral Maxillofac Implants. 2023 Dec 12;38(6):1105–114. doi: 10.11607/jomi.10284.